Comparison of contrast enhanced ultrasonography (CEUS) to conventional sonography for transrectal ultrasound guided prostate biopsies

ISRCTN ISRCTN08205352
DOI https://doi.org/10.1186/ISRCTN08205352
Secondary identifying numbers N0132167130
Submission date
29/09/2006
Registration date
29/09/2006
Last edited
26/02/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Z Bosanac
Scientific

Imaging Department
Medway Maritime Hospital
Windmill Road
Gillingham
ME7 5NY
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeDiagnostic
Scientific titleComparison of contrast enhanced ultrasonography (CEUS) to conventional sonography for transrectal ultrasound guided prostate biopsies
Study objectivesTo determine whether contrast enhanced ultrasound is more accurate in diagnosing prostate cancer than the traditionally used black and white ultrasound.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedCancer: Prostate
InterventionRandomised controlled trial
Intervention typeOther
Primary outcome measureThe clinician performing the prostate biopsies will define the 10 biopsied areas as normal or abnormal. This classification will then be compared to the final pathological examination of the biopsy and the sensitivity and specificity of each move of sonography will be calculated.
Secondary outcome measuresNot provided at time of registration
Overall study start date01/08/2005
Completion date01/08/2006

Eligibility

Participant type(s)Patient
Age groupAdult
SexMale
Target number of participantsNot provided at time of registration
Key inclusion criteriaAll men whose plasma PSA levels warrant prostate biopsies.
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/08/2005
Date of final enrolment01/08/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Imaging Department
Gillingham
ME7 5NY
United Kingdom

Sponsor information

Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Government

The Department of Health, Richmond House, 79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

Medway NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

26/02/2020: No publications found. All search options exhausted.